India
· Delayed Price · Currency is INR IOL Chemicals and Pharmaceuticals Statistics
Total Valuation
IOL Chemicals and Pharmaceuticals has a market cap or net worth of INR 25.26 billion. The enterprise value is 24.44 billion.
| Market Cap | 25.26B |
| Enterprise Value | 24.44B |
Important Dates
The next estimated earnings date is Tuesday, November 12, 2024.
| Earnings Date | Nov 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
IOL Chemicals and Pharmaceuticals has 58.71 million shares outstanding. The number of shares has decreased by -0.05% in one year.
| Shares Outstanding | 58.71M |
| Shares Change (YoY) | -0.05% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 2.04% |
| Owned by Institutions (%) | 2.48% |
| Float | 22.16M |
Valuation Ratios
The trailing PE ratio is 21.31 and the forward PE ratio is 13.08.
| PE Ratio | 21.31 |
| Forward PE | 13.08 |
| PS Ratio | 1.22 |
| PB Ratio | 1.57 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 20.62 |
| EV / Sales | 1.18 |
| EV / EBITDA | 11.64 |
| EV / EBIT | 16.98 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.16 |
| Debt / FCF | n/a |
| Interest Coverage | 15.92 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | 5.57% |
| Revenue Per Employee | 7.46M |
| Profits Per Employee | 426,864 |
| Employee Count | 2,777 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -6.04% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -6.04% |
| 50-Day Moving Average | 451.93 |
| 200-Day Moving Average | 419.00 |
| Relative Strength Index (RSI) | 38.60 |
| Average Volume (20 Days) | 61,024 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IOL Chemicals and Pharmaceuticals had revenue of INR 20.72 billion and earned 1.19 billion in profits. Earnings per share was 20.20.
| Revenue | 20.72B |
| Gross Profit | 6.82B |
| Operating Income | 1.44B |
| Pretax Income | 1.60B |
| Net Income | 1.19B |
| EBITDA | 2.10B |
| EBIT | 1.44B |
| Earnings Per Share (EPS) | 20.20 |
Balance Sheet
The company has 1.15 billion in cash and 327.60 million in debt, giving a net cash position of 822.90 million or 14.02 per share.
| Cash & Cash Equivalents | 1.15B |
| Total Debt | 327.60M |
| Net Cash | 822.90M |
| Net Cash Per Share | 14.02 |
| Equity (Book Value) | 16.12B |
| Book Value Per Share | 274.51 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 32.92%, with operating and profit margins of 6.95% and 5.72%.
| Gross Margin | 32.92% |
| Operating Margin | 6.95% |
| Pretax Margin | 7.72% |
| Profit Margin | 5.72% |
| EBITDA Margin | 10.13% |
| EBIT Margin | 6.95% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 5.00, which amounts to a dividend yield of 1.16%.
| Dividend Per Share | 5.00 |
| Dividend Yield | 1.16% |
| Dividend Growth (YoY) | 25.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.05% |
| Shareholder Yield | 1.22% |
| Earnings Yield | 4.69% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |